Nitecapone

Nitecapone

CAT N°: 18656
Price:

109.00 92.65

Nitecapone is a reversible inhibitor of S-catechol-O-methyltransferase (S-COMT; IC50 = 300 nM in rat liver).{22704} It is selective for S-COMT over tyrosine hydroxylase, dopamine-?-hydroxylase, DOPA decarboxylase, monoamine oxidase A (MAO-A), and MAO-B (IC50s = >1 µM for all). In vivo, nitecapone inhibits liver, duodenal, and brain S-COMT (ID50s = 5, 5, and 25 mg/kg, respectively). Nitecapone (3–30 mg/kg) reduces 3-O-methyl-DOPA (3-OMD) formation and increases serum and brain L-DOPA, dopamine, and DOPAC levels when administered in combination with L-DOPA (Item No. 13248) and carbidopa (Item No. 23783). Nitecapone (30 mg/kg) reduces mechanical and cold allodynia in a rat model of spinal nerve ligation-induced neuropathy.{30152}

We also advise you